The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium.
AIM:The objective of this study was to evaluate the prognostic value of ARID1A, p53, p21, p16 and ß-Catenin in endometrioid and clear cell ovarian and endometrial carcinomas. MATERIALS AND METHODS:97 tumors were available for analysis of ARID1A, p53, p21, p16 and ß-Catenin with the techniques of tis...
Main Authors: | Marlene Heckl, Elisa Schmoeckel, Linda Hertlein, Miriam Rottmann, Udo Jeschke, Doris Mayr |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5815611?pdf=render |
Similar Items
-
The Association between Primary Endometrioid Carcinoma of the Ovary and Synchronous Malignancy of the Endometrium
by: Catharina C. van Niekerk, et al.
Published: (2010-01-01) -
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming
by: Yohan Suryo Rahmanto, et al.
Published: (2020-06-01) -
Clear cell/endometrioid type ovarian carcinoma associated with endometriosis of the ipsilateral ovary
by: Rudić-Biljić-Erski Ivana, et al.
Published: (2019-01-01) -
Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
by: Sachiko Morioka, et al.
Published: (2019-02-01) -
Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium.
by: Kate Lawrenson, et al.
Published: (2015-01-01)